CORCEPT THERAPEUTICS INC ($CORT)
Filing Information
| Accession Number | 0001193125-26-256011 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 3, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
121,663
Total Value
$3,642,886.76
P&L
+112.6% (+$50,301.56)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jun 1, 2026 | Exercise/Conversion | 40,000 | $19.26 | $770,400.00 | 55,257 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 1, 2026 | Sale | 40,000 | $70.00 | $2,800,004.00 | 15,257 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 1, 2026 | Grant/Award | 634 | $70.44 | $44,658.96 | 15,891 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 1, 2026 | Grant/Award | 634 | $0.00 | $0.00 | 16,525 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 2, 2026 | Tax Withholding | 395 | $70.44 | $27,823.80 | 16,130 | Direct | โ | View Details | |
Chief Financial Officer | Stock option (right to buy) | Derivative | Jun 1, 2026 | Exercise/Conversion | 40,000 | $0.00 | $0.00 | 60,000 | Direct | โ | View Details |